Delphi has advised AddLife AB and its subsidiary AddLife Development AB.
AddLife signed an agreement with SIAD Healthcare s.p.a. on the acquisition of their business in the product area of advanced surgery. The business has sales of approximately EUR 8 million on the Italian market in a segment in which AddLife is already an established supplier on the Nordic and central-European markets.
SIAD Healthcare s.p.a. markets and sells products from leading suppliers in advanced surgery, such as neurosurgery, spinal surgery, plastic surgery, interventional radiology, as well as products for advanced wound care. In conjunction with the acquisition, the business will be transferred to a newly formed company, which AddLife is acquiring.
The headquarters are in Assago (Milan) and sales are via own sales resources as well as through regional agents. The products are sold primarily to customers in public and privately funded care. The business has 17 employees and annual sales of approximately EUR 8 million on the Italian market.
AddLife is an independent distributor within Life Science that offer high-quality products, services and advice to both the private and public sectors. The corporation develops and acquires profitable companies in selected niche areas in the segments diagnostics, biomedical research and laboratory analysis and medtech. In 2019, AddLife had a turnover of SEK 3,479 million.
Delphi’s team was led by Fredrik Mörner (Picture).
Involved fees earner: Fredrik Mörner – Delphi Advokatfirman;
Law Firms: Delphi Advokatfirman;